| Display title | Chemistry:BU09059 |
| Default sort key | BU09059 |
| Page length (in bytes) | 3,495 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 323196 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>MedAI |
| Date of page creation | 17:02, 18 August 2023 |
| Latest editor | imported>MedAI |
| Date of latest edit | 17:02, 18 August 2023 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | BU09059 is a potent, selective, short-acting (non-"inactivating") antagonist of the κ-opioid receptor (KOR). It was derived from the irreversible (long-acting) KOR antagonist JDTic in search of an antagonist with a reversible profile of inactivation of the KOR that could be used with less concern to... |
